Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Aims Cardiac resynchronization therapy with (CRTD) or without (CRTP) defibrillator is
recommended in selected patient with systolic chronic heart failure and wide QRS. There is …

The past year has brought many new concepts and an abundance of new data on the
nature, management, and outcome of heart failure. The pace of change is accelerating. We …

Aims We tested the hypothesis that shortening of time‐to‐peak left ventricular pressure rise
(Td) reflect resynchronization in an animal model and that Td measured in patients will be …

Clinical research has transformed the lives and expectations of many patients with heart
failure, especially for those aged< 75 years with symptomatic, clinically stable, chronic heart …

Background Trends of de novo implantation of cardiac implantable electronic devices
(CIEDs) including implantable cardioverter‐defibrillator (ICD) and cardiac resynchronization …

Background We hypothesized that multiple cardiovascular comorbidities, incorporated in the
CHA 2 DS 2‐VAS c score, may be useful in the assessment of ventricular tachyarrhythmias …

Background Cardiac resynchronisation therapy (CRT) is a well-established form of treatment
for patients with heart failure and cardiac dyssynchrony. There are two different types of CRT …